Drdgold Ltd
DRD NYSE· Gold And Silver Ores
Last close · Oct 30, 2026
$22.63
KIRA · Stoqly’s AI analyst, in plain words
- Drdgold Ltd had $660M of revenue in fiscal 2026, up 52.2% on the year before. Over five years, revenue changed +14.1% a year on average.
- Its operating margin was 51.4%, up 14.4 pts: of every 100 in sales, about 51 is left after running the business.
- Drdgold Ltd made $252M of net profit in fiscal 2026. From fiscal 2017 to 2026, diluted EPS grew 2.3% a year.
- Free cash flow was $127M in fiscal 2026, 19.2% of revenue.
- Drdgold Ltd returned $46.1M to shareholders in fiscal 2026, 36% of free cash flow. The diluted share count rose 0.4%.
Market cap
$2.0B
P/E
7.8x
Revenue
$660M
Net income
$252M
Free cash flow
$127M
Operating margin
51.4%
Drdgold Ltd in 30 seconds · fiscal 2026
Are sales growing?
+52.2%
Yes. Sales grew 52.2% last year.
Does it make a profit?
38.1%
Yes. It keeps 38.1% of every sale as profit.
Does profit turn into cash?
19.2%
Yes. 19.2% of sales ends up as free cash.
How healthy are the accounts?
6 / 8
Mixed. It passes 6 of 8 health tests.
How is the share priced?
7.8x
One share costs 7.8 times its yearly profit per share.
What Drdgold Ltd does
No business description yet.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 20-F · Oct 2, 2026
- Legal name
- DRDGOLD LTD
- CIK
- 0001023512
Drdgold Ltd · DRD · stoqly.net
Results and finances
The last 5 fiscal years. Amounts in USD. Compiled by stoqly.net.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $336M | $309M | $333M | $434M | $660M |
| Revenue growth | −1.6% | −8.1% | 7.8% | 30.1% | 52.2% |
| Gross margin | 26.9% | 28.8% | 29.0% | 39.7% | 53.5% |
| Operating margin | 25.5% | 25.9% | 25.8% | 37.0% | 51.4% |
| Net income | $73.9M | $72.1M | $71.0M | $123M | $252M |
| Net margin | 22.0% | 23.3% | 21.3% | 28.5% | 38.1% |
| Diluted EPS | $0.86 | $0.83 | $0.82 | $1.43 | $2.89 |
| Cash | |||||
| Cash from operations | $98.5M | $93.2M | $98.6M | $193M | $336M |
| Capital expenditure | $38.4M | $64.5M | $160M | $124M | $209M |
| Free cash flow | $60.1M | $28.7M | −$61.0M | $69.2M | $127M |
| FCF margin | 17.9% | 9.3% | −18.3% | 15.9% | 19.2% |
| Dividends paid | $33.7M | $29.0M | $39.1M | $23.7M | $46.1M |
| Share count change | −0.0% | 0.5% | 0.1% | 0.1% | 0.4% |
| Debt and strength | |||||
| Cash and short-term investments | $154M | $130M | $28.6M | $73.5M | $169M |
| Shareholders' equity | $332M | $331M | $378M | $500M | $779M |
| Current ratio | 4.9x | 4.5x | 1.6x | 2.3x | 3.6x |
| Interest coverage | 17.5x | 20.1x | 21.1x | 39.7x | 57.4x |
| Returns and quality | |||||
| Return on equity | 22.1% | 21.7% | 20.0% | 28.1% | 39.4% |
| Return on tangible equity | 22.2% | 21.8% | 18.8% | 24.7% | 32.3% |
| Piotroski F-score | 5 | 4 | 4 | 6 | 6 |
| Altman Z'' | 6.8 | 6.8 | 4.6 | 5.7 | 7.2 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.4M
10 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Drdgold Ltd · DRD · stoqly.net
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $22.63 a share, the company is worth $2.0B: 7.8 times its earnings of the last four quarters.
Compiled and analysed by stoqly.net from SEC EDGAR XBRL filings (CIK 0001023512). Latest version: stoqly.net/companies/drd. Data updated November 1, 2026. Filed in ZAR under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.